Clinical Research Committee
Jingsong Zhang, MD, PhD (Chair)
Dr. Zhang is a Genitourinary Oncologist and Interim Vice Chair, Department of Genitourinary Oncology at Moffitt Cancer Center, as well as an Associate Professor of Oncology and Internal Medicine at the University of South Florida College of Medicine. His primary research interest is in integrating tumor evolution dynamics into the treatment for advanced prostate cancer. As the clinical research director of Moffitt cancer center’s genitourinary oncology program, he has been the principal Investigator (PI) and co-investigator of > 50 phase I, II and III clinical studies since joining Moffitt in July 2010. He is also the co-investigator on R21, R01, U01, U54 grants to study adaptive androgen deprivation therapy and immunotherapy in metastatic prostate cancer.
Feng-Ming (Spring) Kong, MD, PhD (Co-Chair)
Dr. Kong is an American Board-Certified Radiation Oncologist. She is the leader of a Peacock Project on Innovative Clinical Trial Platform & RT and Immunotherapy while also working as Professor and Director of Imaging and Blood Biomarker Group (IBBG) at the University of Hong Kong. She is also Deputy Director of Medical Cancer Center and Director of Thoracic Oncology Center at Hong Kong University Shenzhen Hospital. Dr. Kong has also served as the President of Global Collaborative Oncology Group (GCOG) since 2019. She is a Fellow of American College of Radiology (FACR), Fellow of American Association for Women Radiologists/Radiation Oncologists (FAAWR), and Fellow of American Society of Radiation Oncology (FASTRO). She has received numerous awards such as ASCO YIA and ASCO CDA, has over 250 publications (8500+ cittaions), listed in the top 1% scholar for citations in 2020, has reviewed 20+ journals and served as editorial board member of many top journals including Red Journal, Clinical Lung Cancer, and JCO (IF=50).
Xueyu (Eric) Chen, MD, PhD
Dr. Chen is a staff physician at the Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, Toronto, Canada, and an associate professor of medical at Faculty of Medicine, University of Toronto. His clinical activities focus on the treatment of gastrointestinal cancers. He participates in clinical trials evaluating new agents and treatment strategies for gastrointestinal cancers.
Onyee Chan, MD
Dr. Chan received her MD degree from the University of Arizona College of Medicine, Phoenix. She completed an Internal Medicine Residency at the University of Arizona College of Medicine in Tucson, followed by a Hematology/Oncology Fellowship at Moffitt Cancer Center/University of South Florida. She is currently an assistant professor and clinical investigator at the Moffitt Cancer Center. Dr. Chan’s clinical interests include myeloid malignancies, specifically acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Her research interests include clinical trials and outcome studies inspired by molecular targets that focus on myeloid neoplasms.
Richard Lin, MD, PhD
As a hematologist oncologist, I strive to deliver the best possible care to older patients with hematologic malignancies through both standard of care and clinical trial options in transplantation and chimeric antigen receptor T (CAR T) therapy. At MSK, I work together with a multidisciplinary team and leverage my clinical expertise in geriatrics supportive care and state of art therapeutics and clinical trials. As a clinical investigator, I conduct clinical translational studies in hematological malignancy, transplantation, cellular therapy, and geriatrics/supportive care to improve outcomes for older patients including function, cognition, and quality of life.